Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > All Ingredients News

Evonik expands silanes distribution deal with Safic-Alcan

10-Feb-2016 - Safic-Alcan will sell chemicals used in the synthesis of antibiotics and APIs to drug ingredient firms in Italy under a new deal with Evonik.

Earthquake proof API plants a must in Taiwan according to Scinopharm

09-Feb-2016 - Most buildings in Taiwan are designed to withstand earthquakes according to Scinopharm, which told us such measures allowed its Tainan plant to survive a quake that felled a neighbouring tower block last week.

Scinopharm escapes Taiwan earthquake unscathed; API operations unaffected

08-Feb-2016 - Scinopharm has confirmed that its API manufacturing facility in Tainan was not damaged by the earthquake that struck Taiwan last week.

Chemical distribution trade group opens door to manufacturers

08-Feb-2016 - A newly established trade group has invited chemical manufacturers to apply for membership and announced plans to look at API and pharma-related issues.

CPhI report: enter US market or get left behind

08-Feb-2016 - The new report indicates that the US CMO market is poised for significant growth and urges international companies to enter the market – or be left behind.

Made in China: Envirotainer teams with drug and API shipper Air China Cargo

03-Feb-2016 - Envirotainer has partnered with Air China Cargo in deal that will see local and international drug and API makers use its range of cold chain shipping containers.

Indonesia mulls foreign JVs and reduction on imports to boost local API production

02-Feb-2016 - Incoming Indonesian government measures to attract foreign manufacturing joint ventures (JVs) could include a regulation to reduce API imports, Vincent Harijanto, committee head GP Farmasia said.

Novasep expands API lab to grow US sales after Pharmachem divestiture

02-Feb-2016 - Novasep has announced it is expanding API synthesis its facility in Boothwyn, Pennsylvania and confirmed that US growth is important after the sale of Pharmachem.

Surging demand for APIs prompts expansion of second Onyx facility

01-Feb-2016 - Onyx Scientific will add a 6250sq ft facility at its site in North-East England to cope with a surge in demand for its small-scale API services.

Ipca not surprised by US FDA warning at three Indian API plants

01-Feb-2016 - Ipca has received an FDA Warning Letter at three Indian API facilities, but says it awaits re-inspection after already rectifying issues highlighted in a 2014 Form 483.

Johnson Matthey expands Cambridge catalysis facility

21-Jan-2016 - Johnson Matthey has expanded its UK biocatalysis R&D operations in response to growing drug industry demand.

Novozymes says pharma won't drive growth and sets up albumin subsidiary

20-Jan-2016 - Novozymes has launched its albumin operations as a stand-alone subsidiary and reiterated that its pharma business is no longer a growth driver.

Colorcon sweetens its offering with Paulaur's pharma sugar sphere biz

19-Jan-2016 - Colorcon has acquired Paulaur Corporation’s sugar sphere business to help feed pharma’s demand for multiparticulate dosage forms.

US FDA and French regs hit separate Chinese API makers with warnings

14-Jan-2016 - Systemic data manipulation has landed Chinese API maker Zhejiang Hisun Pharmaceutical with a US FDA warning letter.


Better data can encourage industry to trial generics for new indications

13-Jan-2016 - Higher quality data could convince pharma firms to pay to trial generic drugs for new indications say researchers calling for diclofenac to be studied as a cancer treatment.

UK pharma manufacturing output to grow in 2016 says EEF

12-Jan-2016 - UK pharma manufacturing output increased last year according to EEF, which says lower costs and a legacy of R&D investment will drive further growth in 2016.

Kalbe Farma to build Indonesian facility to tackle import challenges

06-Jan-2016 - Kalbe Farma has launched construction plans for a local raw materials facility in a bid to tackle import challenges.

Zydus Cadila Indian plants hit by US FDA warning letter

04-Jan-2016 - Cadila Healthcare has received a US FDA warning letter citing GMP deviations at an API plant and a formulation facility in Ahmedabad, India.

Martin Shkreli charged with securities fraud

18-Dec-2015 - ‘Twas the week before Christmas, and what do you know?

More systems training needed to help inspectors spot data falsification say PIC/S experts

16-Dec-2015 - Data falsification at API facilities is getting harder to spot say regulators who have called for more systems training and international collaboration.

Exec tasked with helping Lonza address "Visp challenge" to step down

14-Dec-2015 - Beat In-Albon, the man tasked with improving profitability at Lonza’s manufacturing site in Visp, Switzerland, will step down at the end of the year.

US FDA warns compounders of contaminated baclofen API from China

14-Dec-2015 - The US FDA has alerted compounders of potential particulate matter in an API sourced from Chinese drugmaker Taizhou Xinyou Pharmaceutical & Chemical.

DuPont and Dow to merge

11-Dec-2015 - DuPont and The Dow Chemical Company have ended speculation by announcing they are to merge and the combined company will be called DowDuPont.

Ingredient importers: Get ACE in place by February, says US FDA

10-Dec-2015 - A new system will simplify and speed-up US imports of pharma ingredients the FDA says, but industry needs to be on board by the end of February.

Severe shortage? 1,500 inspectors too few for India's 10,000 plants says ASSOCHAM

09-Dec-2015 - New Delhi industry group ASSOCHAM says international criticism of Indian drug and API plants is due to a ‘severe shortage’ of regulatory inspectors.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...